Joel Sendek, Chief Financial Officer at Spero Therapeutics, Inc. (SPRO), bought 15,181 shares at $14.00 ($70K) on 2017-11-06, disclosed to the SEC on 2017-11-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 10,181 | $0 | 0.0% |
| 2 | $14.00 | 5,000 | $70K | 100.0% |
| Total | $4.61 avg | 15,181 | $70K | 100% |